Outpatient and Home Advanced Rehabilitation Therapeutics Using Jintronix Virtual Reality Telerehabilitation System

April 1, 2020 updated by: Tan Tock Seng Hospital
The use of virtual reality technology in a telerehabilitation service is not well established in Singapore. This feasibility trial aims to evaluate the benefits of using Jintronix to deliver a clinic-to-home, caregiver-supervised and individualised exercise telerehabilitation program to complement outpatient services and improve clinical outcomes for post-stroke users.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

35

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patients with motor deficits due to stroke as diagnosed by CT or MRI, who are attending outpatient rehabilitation services at Tan Tock Seng Hospital Rehabilitation Centre and Centre for Advanced Rehabilitation Therapeutics
  • post stroke of at least 3 months with stable neurological status
  • 21-75 years old
  • able to perform at minimal level of assistance (i.e. carer provides only up to 25% of physical support) for sitting, standing and/or walking tasks
  • has a primary caregiver that must be present in all trial sessions
  • able to understand and participate in a 15 minutes Jintronix trial during screening

Exclusion Criteria:

  • has seizure history
  • has severe cognitive deficits, perceptual deficits, and/or emotional-behavioural issues
  • has unstable medical conditions which may affect participation (e.g unresolved sepsis, postural hypotension, end stage renal failure) or anticipated life expectancy of <1 year due to malignancy or neurodegenerative disorder
  • has pain score of >5
  • is pregnant or breastfeeding
  • has known poor cardiac ejection fraction (<30%) or lung function (FEV1<30%)
  • has non-weight bearing status in either lower extremities
  • has caregiver who is unable to meet competency requirements as assessed by study team

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Jintronix Intervention

2 consecutive phases of intervention for all participants using Jintronix virtual reality telerehabilitation software.

Phase 1 consisted of 9 (3/week for 3 weeks) 45-min/session clinic-based sessions conducted by study team therapist, with concurrent caregiver training.

Phase 2 consisted of 20 (5/week for 4 weeks) 45min/session home-based sessions supervised by trained caregiver, with telemonitoring by study team therapist.

System consists of an internet-based rehabilitation software linked to a Microsoft Kinect camera for motion detection.

Study team therapist prescribed a list of guided exercises and therapeutic activities (games) for training of whole body, lower and upper extremities. These can be done in sitting or standing, depending on individual participant's capacity.

Telemonitoring is done by study team therapist during each of the training day (Mondays-Fridays) of the home-based training phase. Training performance results are reviewed and training games are adjusted or changed to optimise home training.

Other Names:
  • Jintronix

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fugl Meyer Upper Limb Motor Assessment
Time Frame: Week 0
Measures motor impairment of upper limb recovery from a neurological insult.
Week 0
Change of Fugl Meyer Upper Limb Motor Assessment Score from Week 0
Time Frame: Week 3
Measures change of motor impairment of upper limb recovery from a neurological insult.
Week 3
Change of Fugl Meyer Upper Limb Motor Assessment Score from Week 3
Time Frame: Week 7
Measures change of motor impairment of upper limb recovery from a neurological insult.
Week 7
Change of Fugl Meyer Upper Limb Motor Assessment Score from Week 7
Time Frame: Week 11
Measures change of motor impairment of upper limb recovery from a neurological insult.
Week 11
Berg Balance Scale
Time Frame: Week 0
Measures static and dynamic balance abilities.
Week 0
Change of Berg Balance Scale Score from Week 0
Time Frame: Week 3
Measures change of static and dynamic balance abilities.
Week 3
Change of Berg Balance Scale Score from Week 3
Time Frame: Week 7
Measures change of static and dynamic balance abilities.
Week 7
Change of Berg Balance Scale Score from Week 7
Time Frame: Week 11
Measures change of static and dynamic balance abilities.
Week 11
6 Minute Walk Test
Time Frame: Week 0
Measures endurance inferred from distance walked over 6 minutes.
Week 0
Change of 6 Minute Walk Test Score from Week 0
Time Frame: Week 3
Measures change of endurance inferred from distance walked over 6 minutes.
Week 3
Change of 6 Minute Walk Test Score from Week 3
Time Frame: Week 7
Measures change of endurance inferred from distance walked over 6 minutes.
Week 7
Change of 6 Minute Walk Test Score from Week 7
Time Frame: Week 11
Measures change of endurance inferred from distance walked over 6 minutes.
Week 11
10 Meter Walk Test
Time Frame: Week 0
Measures walking speed over 10 meters.
Week 0
Change of 10 Meter Walk Test Score from Week 0
Time Frame: Week 3
Measures change of walking speed over 10 meters.
Week 3
Change of 10 Meter Walk Test Score from Week 3
Time Frame: Week 7
Measures change of walking speed over 10 meters.
Week 7
Change of 10 Meter Walk Test Score from Week 7
Time Frame: Week 11
Measures change of walking speed over 10 meters.
Week 11
Pain Score
Time Frame: Week 0
Measures pain subjectively from participant's rating of 0 (no pain) to 10 (worst pain).
Week 0
Change of Pain Score from Week 0
Time Frame: Week 3
Measures change of pain subjectively from participant's rating of 0 (no pain) to 10 (worst pain).
Week 3
Change of Pain Score from Week 3
Time Frame: Week 7
Measures change of pain subjectively from participant's rating of 0 (no pain) to 10 (worst pain).
Week 7
Change of Pain Score from Week 7
Time Frame: Week 11
Measures change of pain subjectively from participant's rating of 0 (no pain) to 10 (worst pain).
Week 11
Stroke Self-Efficacy Questionnaire
Time Frame: Week 0
Measures a stroke survivor's perceived level of confidence in functional performance.
Week 0
Change of Stroke Self-Efficacy Questionnaire Scores from Week 0
Time Frame: Week 7
Measures change of a stroke survivor's perceived level of confidence in functional performance.
Week 7
Change of Stroke Self-Efficacy Questionnaire Scores from Week 7
Time Frame: Week 11
Measures change of a stroke survivor's perceived level of confidence in functional performance.
Week 11
Subjective Feedback Questionnaire
Time Frame: Week11

A. Measures a participant's level of agreement on a 5-point Likert scale with the following points: i. ease of setup; (ii) ease of following instructions of system; (iii) if training was enjoyable; (iv) if therapist was able to monitor participant's performance; (v) if exercises were prescribed at right level of challenge; (vi) if this approach motivated participant to keep up with exercises; and (vii) if such training should be recommended to others.

B. Additional comments with regards to participants' experiences in the study, if any, were also collected.

Week11

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Wee Keong Christopher Kuah, MSc, Tan Tock Seng Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 5, 2017

Primary Completion (Actual)

November 14, 2018

Study Completion (Actual)

November 14, 2018

Study Registration Dates

First Submitted

March 17, 2020

First Submitted That Met QC Criteria

April 1, 2020

First Posted (Actual)

April 3, 2020

Study Record Updates

Last Update Posted (Actual)

April 3, 2020

Last Update Submitted That Met QC Criteria

April 1, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • NHG DSRB 2016/00442

Drug and device information, study documents

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Jintronix Virtual Reality Telerehabilitation System

3
Subscribe